OUR SCIENCE
Industrial property
Extensive patent portfolio
Our commitment to developing innovative therapies has led us to build a broad, globally extended patent portfolio that continues to grow with new advances and innovations resulting from our ongoing research and development work.
International coverage
With extension in more than 50 territories worldwide, we currently have a portfolio of more than 270 granted patents and pending applications, covering oligonucleotides and RNAi products that regulate the expression of proteins involved in different diseases, and their use in therapy, mainly for ophthalmological indications.
SirFinder™
In addition, we have our own artificial intelligence-based software, SirFinder™, which integrates the knowledge and experience acquired throughout our trajectory, this allowing us to design candidate siRNAs against any gene and with suitability for further development.
See more
Español